Futura Medical (FUM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

35.40p
   
  • Change Today:
    -0.40p
  • 52 Week High: 65.00
  • 52 Week Low: 25.50
  • Currency: UK Pounds
  • Shares Issued: 301.45m
  • Volume: 241,540
  • Market Cap: £106.71m
  • RiskGrade: 479

Cash Flow

  £ (Millions) £ (Millions) £ (Millions)
Cash Flow Statement 31-Dec-10 31-Dec-09 31-Dec-08
       
Net Cash Flow From Operating Activities (1.05) (1.32) (1.97)
ROI, Servicing of Finance      
Assocs/JV Dividends Received bn/a bn/a bn/a
Interests & Other Dividends Received n/a n/a n/a
Interest Paid bn/a bn/a bn/a
Minorities & Non-Equity Divs Paid bn/a bn/a bn/a
  n/a n/a n/a
       
Taxation Paid bn/a bn/a bn/a
       
Gross Cash Flow bn/a bn/a bn/a
       
Capital Expd & Financial Inv      
Interests & Other Dividends Received 0.02 0.01 0.12
Disposal of Property, Plant & Equipment n/a n/a n/a
Disposal of Investments n/a n/a n/a
Purchase of Property, Plant & Equipment (0.01) n/a n/a
Purchase of Investments n/a n/a n/a
Net Purchase of Intangible Assets n/a n/a n/a
Other Investing Cash Flow n/a n/a n/a
  0.02 0.01 0.12
Financing Activities      
Dividends Paid n/a n/a n/a
Repayments of Borrowings n/a n/a n/a
Borrowings n/a n/a n/a
Other Financing Cash Flow 0.07 2.32 n/a
  0.07 2.32 n/a
Net Increase/Decrease In Cash (0.96) 1.01 (1.86)


Key Financials 31-Dec-10 31-Dec-09 31-Dec-08
       
Shares in Issue - Year End 67.64 67.48 57.62
       
Financial Data      
Cash Incr/Decr per Share (1.43p) 1.62p (3.22p)
Operating Cash Flow per Share (1.55p) (2.12p) (3.42p)
Gross Cash Flow per Share bn/a bn/a bn/a
       
Market Data      
Price/Operating Cash Flow (45.9) (17.6) (8.8)

Key

* GAAP

a. Operating activities before tax

b. Not disclosed under IFRS

c. Not previously included in financing activities

d. Based on operating cash flow before tax

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: Forecast figures based on normalised accounts.

 

Top of Page